VYGR - Voyager Therapeutics, Inc.

QQQ $ 453.22 $ -0.27 (-0.06 %)

DIA $ 400.20 $ 0.56 (0.14 %)

SPY $ 530.16 $ 0.20 (0.04 %)

TLT $ 92.04 $ -0.35 (-0.38 %)

GLD $ 220.22 $ 0.22 (0.1 %)

Previous Close

$ 8.57

Open

$ 8.50

Bid

$ 0.00 x 0

Ask

$ 8.55 x 100

Day's Range

$ 8.33 - $ 8.75

52 Week Range

$ 6.06 - $ 14.34

Volume

510,531

Average Volume

Market Cap

489.49M

Beta (5Y Monthly)

$ 1.29

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-13-2024	03-31-2024	10-Q
2	02-28-2024	12-31-2023	10-K
3	11-06-2023	09-30-2023	10-Q
4	08-03-2023	06-30-2023	10-Q
5	05-09-2023	03-31-2023	10-Q
6	03-07-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-04-2022	03-31-2022	10-Q
10	03-08-2022	12-31-2021	10-K
11	11-02-2021	09-30-2021	10-Q
12	08-09-2021	06-30-2021	10-Q
13	05-10-2021	03-31-2021	10-Q
14	02-25-2021	12-31-2020	10-K
15	11-09-2020	09-30-2020	10-Q
16	08-10-2020	06-30-2020	10-Q
17	05-06-2020	03-31-2020	10-Q
18	03-03-2020	12-31-2019	10-K
19	11-06-2019	09-30-2019	10-Q
20	08-09-2019	06-30-2019	10-Q
21	05-07-2019	03-31-2019	10-Q
22	02-26-2019	12-31-2018	10-K
23	11-07-2018	09-30-2018	10-Q
24	08-07-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	03-14-2018	12-31-2017	10-K
27	11-02-2017	09-30-2017	10-Q
28	08-08-2017	06-30-2017	10-Q
29	05-09-2017	03-31-2017	10-Q
30	03-15-2017	12-31-2016	10-K
31	11-10-2016	09-30-2016	10-Q
32	08-11-2016	06-30-2016	10-Q
33	05-12-2016	03-31-2016	10-Q
34	03-17-2016	12-31-2015	10-K
35	12-17-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Voya...
05/16/2024 17:30:02

HC Wainwright & Co. analyst Patrick Trucchio reiterates Voyager Therapeutics (NASDAQ:VYGR) with a Buy and maintains $30 ...

Voyager Therapeutics Says First Participan...
05/16/2024 11:15:03

Oppenheimer Maintains Outperform on Voyage...
05/15/2024 15:40:19

Oppenheimer analyst Jay Olson maintains Voyager Therapeutics (NASDAQ:VYGR) with a Outperform and maintains $18 price target.

Wedbush Maintains Neutral on Voyager Thera...
05/14/2024 12:32:23

Wedbush analyst Laura Chico maintains Voyager Therapeutics (NASDAQ:VYGR) with a Neutral and lowers the price target from $10...

Voyager Therapeutics Reports Cash Position...
05/13/2024 20:04:37

Voyager Therapeutics Q1 2024 GAAP EPS $(0....
05/13/2024 20:02:41

Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of ...

Voyager Therapeutics Presents Data for Sec...
05/08/2024 10:12:34

Translational potential of TRACER-derived AAV capsids demonstrated by data across multiple species (murine, porcine, multiple...

Voyager Therapeutics To Present Translatio...
04/22/2024 20:31:45

Selection Of The Development Candidate Tri...
04/16/2024 11:12:24

Voyager Therapeutics And Neurocrine Biosci...
04/16/2024 11:07:51

Voyager Therapeutics And Neurocrine Biosci...
04/16/2024 11:06:21

Voyager Therapeutics Said Co And CFO Peter...
04/02/2024 20:36:35

-8-K

Guggenheim Initiates Coverage On Voyager T...
03/26/2024 10:39:06

Guggenheim analyst Debjit Chattopadhyay initiates coverage on Voyager Therapeutics (NASDAQ:VYGR) with a Buy rating and annou...

analyst-bullish-on-gene-therapy-focused-voyager-therapeutics-sees-best-in-class-potential-for-its-neurogenetic-medicine-platform

Analyst Bullish On Gene Therapy-Focused Vo...
03/19/2024 18:16:11

Unlock potential with Voyager Therapeutics as HC Wainwright initiates coverage highlights its TRACER capsid platform, promising...

HC Wainwright & Co. Initiates Coverage On ...
03/19/2024 10:50:17

HC Wainwright & Co. analyst Patrick Trucchio initiates coverage on Voyager Therapeutics (NASDAQ:VYGR) with a Buy rating ...

Citigroup Initiates Coverage On Voyager Th...
03/07/2024 08:49:59

Citigroup analyst David Hoang initiates coverage on Voyager Therapeutics (NASDAQ:VYGR) with a Buy rating and announces Price...

tech-stocks-set-to-rise-thursday-as-january-inflation-data-fails-to-scare-markets-small-caps-surge

Tech Stocks Set To Rise Thursday As Januar...
02/29/2024 14:20:35

Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 5...

Why Okta Shares Are Trading Higher By Arou...
02/29/2024 13:04:20

Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-e...

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
02/28/2024 21:31:07

Voyager Therapeutics: Q4 Earnings Insights
02/28/2024 21:30:35